...less...
As a pulmonologist you tend to see a more difficult patient with asthma who has other co-morbidities that make their disease more complicated and difficult to control. In this slide presentation, we discuss the role of allergy in a pulmonologist’s practice. We hope you find this presentation helpful in the treatment of your patients.
This activity was developed for Primary Care Physicians who treat patients with COPD.
1. Describe the role of inflammation in causing COPD and comorbidities. 2. Select the comorbidities most frequently associated with COPD. 3. Explain the role of specific comorbidities in the health and prognosis of the patient, in addition to pulmonary factors.
National Jewish Health is accredited by the Accreditation Council for Continuing medical education to provide continuing medical education for physicians.
National Jewish Health designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity is intended for Family Practice Physicians, Internal Medicine Physicians Assistants, Registered Nurses, and Nurse Practitioners.
May 1, 2010 through April 30, 2012
December 1, 2009 through November 30, 2010
1. Discuss the definition of asthma control as defined by the NAEPP asthma guidelines. 2. Identify cases of severe asthma and indicate management steps as directed by the NAEPP asthma guidelines. 3. Indicate best methods to monitor asthma control and adjust treatment.
This activity was developed for Primary Care Physicians and Physicians who work in Family or Internal Medicine.
Upon completion of this activity, participants will demonstrate the ability to:
This activity has been planned and implemented in accordance with the Essential Areas and Elements, and Accreditation Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of National Jewish Health and Reed Medical Education. National Jewish Health is accredited by the ACCME to provide continuing medication education for physicians.
National Jewish Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity was developed for Physicians, Nurse Practitioners, Physician Assistants, and Registered Nurses who work in Family or Internal Medicine.
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
National Jewish Health is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 12724. This program is approved for 1.2 Nursing Contact Hours.
The reactive, rather than proactive, medical paradigm of the 20th century is still used for many diseases. This approach ignores the natural history, genetic background, and pre-clinical manifestations of disease. In the 21st century, medicine has already become increasingly preventive in an aim to reduce the number of deaths due to genetic predisposition and personal behavior. Genetic information is being used to customize detection, treatment, and prevention at the individual level. The former reactive approach lacks precision, while the new proactive one reduces uncertainty and error in both diagnosis and treatment.
Early work in medical genetics was mostly focused on monogenic disorders, but with the completion of the Human Genome Project, it is now possible to understand diseases caused by environment-gene interaction with more than one genetic variant. A powerful new set of tools, genomics, proteomics, metabolomics, and lipidomics, are at the forefront of biomarker discovery for disease diagnosis. Natural variations across several genes, coupled with environmental factors, is now known to be generally responsible for influencing an individual's risk for developing certain diseases, and explains why some patients respond to a particular drug while others do not. Personalized medicine offers the possibility of specific lifestyle changes, chemoprevention, or nutrigenomic products to delay or prevent onset of a disease.
While personalized medicine is often discussed in the future tense, it is already having an impact and is an unavoidable trend in medicine, enabled by technology and knowledge of 'omics, and spurred by economics and consumerism. It is currently delivering better diagnoses, earlier interventions, more efficient drug development and better therapies, and promising more for the future. In this MedSci Update, we discuss the current status of personalized drug prescription and dosing based on individual genetic profiles, the use of biomarkers in prediction, treatment and monitoring, the integration of 'omics and biomarker technologies with imaging and clinical reference laboratories, and the upcoming challenges for personalized medicine in the technological and social realms.
This activity was developed for Primary Care Physicians, Allergists/ Immunologists, Registered Nurses, Family and General Practitioners, Pediatricians, Pulmonologists, Physician Assistants, and Nurse Practitioners.
National Jewish Medical and Research Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
National Jewish Medical and Research Center designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
